China’s amendments to competition law aimed at tackling unfair behavior online; Cross-border funding pilot program for multinationals extended to 10 provinces and cities; and Chinese court follows Munich courts in granting Huawei an anti-anti-suit injunction against Netgear
Foreign marketing authorization holders are required to designate a domestic responsible person in China ; Clp Reference: 2600/24.11.13 ; Issued: 2024-11-13 ; Effective: 2025-07-01
Dongping Liu and Xin Luo of Zhong Lun Law Firm analyze a significant set of new guidelines which are vital for foreign enterprises with a patent portfolio in China
U.S. attempts to exclude Chinese access to AI chips by designating ‘gatekeeper’ companies; Shein’s UK IPO application scrutinized over forced labor concerns; and China’s AI Standards Committee to include executives from tech giants
AI cannot serve as a patent inventor. China allows wholly foreign-owned hospitals in nine major places. Marketing authorization holders are required to engage a medical representative for pharmaceutical academic promotion activities.
NFRA specifies the non-performing assets that a financial asset management company may acquire.CLP Reference: 3600/24.11.11, Issued: 2024-11-11, Effective: 2024-11-11
Personal information handlers of the Greater Bay Area are required to make publicly available its rules for processing personal information. CLP Reference: 5600/24.11.21, Issued: 2024-11-21
While companies from third countries do not necessarily need to divest from China to invest in the U.S., they should be prepared for CFIUS scrutiny of their China operations
State Intellectual Property Office issues guidelines on AI as patent inventors; German and British companies are less optimistic about their China prospects, with a caveat; and U.S. adds a range of companies involved in Chinese chipmaking to Entity List
